6Liu YM, Kao Yang YH, Hsieh CR. Financial incentives and physicians' prescription decisions on the choice be- tween brand-name and generic drugs: Evidence from Tai- wan[J]. Journal of Health Economics, 2009,28 (2) :341. 被引量：1
8Soonman Kwon. Pharmaceutical reform and physician strikes in Korea: separation of drug prescribing and dis- pensing[J]. Social Science & Medicine, 2003, (57):529. 被引量：1
9Jaume PJ. Incentives and pharmaceutical reimbursement reforms in Spain[J]. Health Policy, 2004, (67) : 149. 被引量：1
10Ivan MT, Jaume P J, Josep MR. The impact of repeated cost containment policies on pharmaceutical expenditure: experience in Spain[J]. Eur J Health Econ, 2010, 12 (6) : 563. 被引量：1
